GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADRB1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HMGCR, HSD17B1, HSD17B2, KDR, MET, MIF, PPARA, PTAFR, SLC1A1, SRC, TERT, TNKS, TNKS2, XDH |
9.79149 |
[BP] GO:0007215 |
None
|
APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.26718 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FUT7, HMGCR, HSD17B1, HSD17B2, MET, MIF, PPARA |
8.17897 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GLO1, HMGCR, MIF, PIM1, PPARA, PTAFR, TYR, XDH |
7.68368 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APEX1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, SRC, TERT |
7.3424 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADRB1, AKR1B1, ALOX15, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FLT3, GRM1, HMGCR, KDR, MET, MIF, MMP12, MMP9, SRC, TERT, TNKS, TNKS2, XDH |
7.31171 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADRB1, AKR1B1, ALOX15, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FLT3, GRM1, HMGCR, KDR, MET, MIF, MMP12, MMP9, SRC, TERT, TNKS, TNKS2, XDH |
7.3096 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, ALOX15, APEX1, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, KDR, MMP2, MMP9, PPARA, PTAFR, SRC, TERT, TYR |
7.29248 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, APEX1, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, KDR, MMP2, PPARA, PTAFR, SRC, TYR |
7.20648 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, MMP2, MMP9, PPARA, PTAFR, SRC, TYR |
7.0846 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7, GRM5, PTAFR |
6.93826 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADRB1, AKR1B1, ALOX15, APP, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
6.88072 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.88072 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADRB1, AKR1B1, ALOX15, APP, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
6.79752 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FUT7, HMGCR, MET, MIF, PPARA |
5.90281 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADRB1, AKR1B1, ALOX15, APP, AXL, CSNK2A1, CYP1B1, EGFR, ERBB2, FLT3, GRM1, HMGCR, KDR, MET, MIF, MMP12, MMP9, SRC, TERT, TNKS, TNKS2, XDH |
5.90281 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADRB1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, SLC1A1, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
5.80398 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.80398 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADRB1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, EGFR, ERBB2, FABP3, FLT3, GRIK5, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
5.56562 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA3, ALOX15, APEX1, APP, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, GRIK5, GRM5, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTAFR, SRC, TERT |
5.5072 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADRB1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, CA2, CA9, CACNA1C, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B2, KDR, MET, MIF, MMP2, MMP9, PIM1, PPARA, PTPRS, SRC, TERT, TNKS2, TOP2A, TYR |
5.48768 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HMGCR, MMP2, MMP9, PTAFR, TERT |
5.3876 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, FLT3, GLO1, GRIK5, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, SRC, TERT, TOP2A, XDH |
5.3876 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, APEX1, APP, AXL, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, MMP9, PTAFR, SRC, TERT |
5.3876 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA3, APP, AXL, CA1, CSNK2A1, EGFR, ERBB2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MIF, MMP2, MMP9, PTAFR, SRC, TNKS, TNKS2 |
5.30616 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, HSD17B2 |
5.29997 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADRB1, AKR1B1, ALOX15, APP, AXL, CSNK2A1, CYP1B1, EGFR, ERBB2, FABP4, FLT3, GRM1, HMGCR, KDR, MET, MIF, MMP12, MMP2, MMP9, PTAFR, SRC, TERT, TNKS, TNKS2, XDH |
5.27784 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, FLT3, GLO1, GRIK5, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
5.2727 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APEX1, APP, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ERBB2, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, PTAFR, SRC |
5.14015 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.14015 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, PIM1, SRC |
5.07728 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, TYR |
5.0733 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, MIF, MMP2, MMP9, PTAFR, SRC, TERT, TOP2A |
5.02063 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA3, APEX1, APP, CACNA1C, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, KDR, MET, MIF, MMP9, PTAFR, SRC, TERT |
4.93166 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, MIF |
4.84507 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA3, AKR1B1, APP, CSNK2A1, CYP1B1, EGFR, ERBB2, FABP3, FLT3, HMGCR, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PTAFR, SRC, TERT, XDH |
4.84507 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, FLT3, GLO1, GRIK5, HMGCR, IGF1R, KDR, MIF, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
4.71727 |
[BP] GO:0042592 |
homeostatic process
|
ADRB1, AKR1B1, APEX1, APP, AXL, CA12, CA2, CA7, CACNA1C, EGFR, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, MET, SRC, TERT |
4.68533 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, APEX1, APP, AXL, CYP1A1, CYP1B1, EGFR, ERBB2, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, PTAFR, SRC |
4.68313 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, MIF |
4.68313 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, APP, CA2, CA7, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8 |
4.68313 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, APP, CA2, CA7, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8 |
4.68313 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA3, APEX1, APP, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, KDR, MET, MIF, MMP9, PTAFR, SRC, TERT |
4.65612 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GLO1, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, SRC, TERT |
4.65612 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
4.59887 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADRB1, AKR1B1, ALOX15, APP, AXL, CYP1B1, EGFR, ERBB2, FLT3, GRM1, HMGCR, KDR, MET, MIF, SRC, XDH |
4.51637 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADRB1, ALOX15, APP, EGFR, ERBB2, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MIF, MMP9, PPARA, PTAFR, SRC, XDH |
4.4835 |
[BP] GO:0032501 |
multicellular organismal process
|
ADRB1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, AXL, CACNA1C, CYP19A1, CYP1A2, CYP1B1, EGFR, FABP4, GRM1, GRM5, GRM8, HMGCR, HSD17B2, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, SRC, TNKS2, TYR |
4.47101 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADRB1, ALOX15, APP, EGFR, ERBB2, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MIF, MMP9, PPARA, PTAFR, SRC, XDH |
4.43888 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.43888 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 |
4.4202 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GLO1, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIM1, SRC, TERT |
4.41827 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA3, ADRB1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HMGCR, HSD17B2, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PPARA, PTAFR, SRC, TERT, TOP2A, TYR |
4.37213 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CSNK2A1, EGFR, ERBB2, FLT3, HMGCR, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PTAFR, TERT |
4.33516 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA3, APEX1, APP, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, KDR, MET, MIF, MMP9, PTAFR, SRC, TERT |
4.30356 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, HSD17B2, TYR, XDH |
4.27842 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.27002 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA3, APEX1, APP, CYP19A1, CYP1B1, EGFR, IGF1R, KDR, MET, MIF, MMP9, PTAFR, SRC, TERT |
4.26551 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.22863 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ERBB2, FLT3, HSD17B2, KDR, PPARA, PTPRS, SRC, TYR |
4.22269 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HMGCR, MMP2, MMP9, PTAFR, TERT |
4.20852 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ALOX15, APP, AXL, CA2, CA7, CACNA1C, CYP19A1, EGFR, ERBB2, GRIK5, GRM5, HMGCR, MIF, MMP12, MMP9, PPARA, PTAFR, SRC, TERT |
4.09374 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, CA2, CA7, GRM5, MIF, PTAFR |
4.07784 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, CA2, CA7, CACNA1C, EGFR, HMGCR, KDR, MIF, SRC, TNKS, TNKS2 |
3.96127 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADRB1, ALOX15, APP, EGFR, ERBB2, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, MIF, MMP9, PTAFR, SRC, XDH |
3.9508 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADRB1, ALOX15, APP, EGFR, ERBB2, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, MIF, MMP9, PTAFR, SRC, XDH |
3.9508 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, MIF, PPARA |
3.86662 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, FABP3, FLT3, HSD17B2, PTAFR, SRC, TYR |
3.85515 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APEX1, APP, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FLT3, PTAFR, SRC, TYR |
3.82624 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GLO1, HMGCR, IGF1R, KDR, MIF, MMP9, PIM1, SRC, TERT |
3.82191 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, APEX1, AXL, CA9, CYP1A1, CYP1B1, EGFR, FABP3, HMGCR, KDR, PTAFR, SRC |
3.76905 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADRB1, AKR1B1, APP, AURKB, CA2, CYP1A1, EGFR, GRM1, HMGCR, MMP2, PPARA, PTAFR, SRC, TERT, TYR |
3.76147 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, MIF |
3.73652 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ALOX15, APP, EGFR, ERBB2, FLT3, GRM1, HMGCR, KDR, MIF, SRC, XDH |
3.71786 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, CYP1B1, EGFR, GRIK5, GRM5, IGF1R, MMP2, MMP9, PTAFR, SRC |
3.68098 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADRB1, AKR1B1, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ERBB2, FLT3, GRM1, HMGCR, IGF1R, KDR, MET, MIF, MMP9, SRC, XDH |
3.68098 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
3.67982 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, APP, CYP19A1, CYP1A1, CYP1B1, HMGCR, PTAFR, TYR |
3.67072 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, TERT |
3.66512 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, EGFR, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, PTAFR, SRC, TYR |
3.66033 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.6346 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA3, ADRB1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FABP3, FABP4, GLO1, GRM3, GRM8, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
3.59476 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADRB1, AKR1B1, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FABP4, FLT3, GRM1, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP2, MMP9, PPARA, PTAFR, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
3.58242 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, CYP1A1, EGFR, ERBB2, FLT3, MET, MIF, PIM1, SRC, TYR |
3.55608 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, APEX1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, PPARA, PTAFR, SRC |
3.52765 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
EGFR, GRM1, GRM3, GRM5, GRM8 |
3.52765 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.5241 |
[BP] GO:0035235 |
None
|
APP, GRIA2, GRIA4, GRIK5 |
3.5241 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 |
3.5241 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.48731 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FABP3, FABP4, GLO1, GRM3, GRM8, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
3.46272 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADRB1, AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
3.43355 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, CYP1A1, EGFR, ERBB2, PPARA |
3.42739 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, EGFR, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, PTAFR, SRC, TYR |
3.36611 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.34634 |
[BP] GO:0010359 |
None
|
ABCB1, GRM5, PTAFR |
3.31712 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA3, ADRB1, AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CACNA1C, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPRS, SLC1A1, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH |
3.31307 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADRB1, ALOX15, APP, AURKB, CSNK2A1, EGFR, ERBB2, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
3.31307 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, APEX1, APP, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, HMGCR, IGF1R, KDR, MET, PIM1, PTAFR, PTPRS, SRC, TNKS, XDH |
3.30423 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1, HMGCR |
3.2772 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, EGFR, ERBB2, HMGCR, KDR, MIF, SRC |
3.27456 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP2, PIM1, PPARA, PTAFR, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
3.2499 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.2499 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ALOX15, APP, EGFR, ERBB2, FLT3, GRM1, HMGCR, IGF1R, KDR, MIF, SRC, XDH |
3.2499 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR, HMGCR |
3.2499 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, MIF, PPARA |
3.2453 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, EGFR, HMGCR, KDR, MIF, SRC |
3.22107 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, KDR, PTAFR, SRC |
3.2082 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.2082 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, FABP4, GRM3, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, SRC, TNKS |
3.14562 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, MET, MMP9, PPARA, SRC, TERT |
3.11926 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, SRC |
3.10955 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, EGFR, GRM5, IGF1R, MMP2, PTAFR, SRC |
3.06723 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADRB1, ALOX15, APP, AURKB, EGFR, ERBB2, FABP3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
3.06703 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, APEX1, APP, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, HMGCR, IGF1R, KDR, MET, PIM1, PTAFR, PTPRS, SRC, TNKS, XDH |
3.05188 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, HMGCR, HSD17B1, HSD17B2 |
3.04545 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA3, ADRB1, APP, AXL, CA2, CACNA1C, CYP1B1, EGFR, ERBB2, GRM1, HMGCR, KDR, MET, MIF, MMP12, MMP9, PIM1, PTAFR, PTPRS, SLC1A1, SRC, TERT, TNKS2, XDH |
3.00219 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADRB1, ALOX15, APP, AURKB, CSNK2A1, EGFR, ERBB2, FABP3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.99938 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRB1, APP, AXL, CA2, CYP1B1, EGFR, HMGCR, KDR, MET, MIF, MMP12, MMP9, PIM1, PTAFR, SLC1A1, SRC, TERT |
2.99776 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADRB1, AKR1B1, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ERBB2, FLT3, GRM1, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
2.97901 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA3, ADRB1, APP, AURKB, CSNK2A1, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, IGF1R, MIF, MMP9, PTAFR, SRC, TERT, TNKS, XDH |
2.90501 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.88556 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.87986 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS |
2.86356 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTAFR, SRC |
2.84549 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, APP, EGFR, GRM5, IGF1R, MMP2, PTAFR, SRC |
2.8348 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, CA12, CA2, CA7, CACNA1C, EGFR, FABP3, FABP4, GRIK5, GRM1, GRM5, MET |
2.83475 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ALOX15, APP, EGFR, ERBB2, FLT3, GRM1, GRM5, HMGCR, KDR, MIF, MMP9, SRC, XDH |
2.82757 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ACHE, ADORA3, ADRB1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPRS, SLC1A1, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.78955 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, HMGCR, HSD17B1, HSD17B2, MIF |
2.78044 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, APP, EGFR, ERBB2, FLT3, GRM5, IGF1R, MMP2, PTAFR, SRC |
2.75806 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, APP, AXL, CA2, CYP19A1, EGFR, ERBB2, MIF, MMP12, PTAFR, SRC, TERT |
2.7557 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, EGFR, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
2.7416 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA3, ADRB1, APP, AURKB, CSNK2A1, CYP1B1, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, IGF1R, MET, MIF, MMP9, PIM1, PPARA, PTAFR, SRC, TERT, TNKS, XDH |
2.72547 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.72167 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX15, CYP19A1, HMGCR, PTAFR, TYR |
2.71274 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
EGFR, ERBB2, FLT3, GRM1, HMGCR, IGF1R, MIF, SRC |
2.71274 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, APP, CYP19A1, EGFR, FABP4, HMGCR, IGF1R, MET, MIF, MMP12, MMP2, PPARA, PTPRS, SRC, TERT, XDH |
2.69966 |
[BP] GO:0007165 |
signal transduction
|
ADORA3, ADRB1, AKR1B1, APP, AXL, CA1, CA2, CACNA1C, CSNK2A1, CYP1B1, EGFR, ERBB2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MIF, MMP2, MMP9, PIM1, PPARA, PTAFR, SRC, TNKS, TNKS2 |
2.69966 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, CYP1B1, EGFR, MMP9, SRC |
2.69487 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, MET, MMP9, PPARA, SRC, TERT, TNKS |
2.69487 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, KDR, SRC |
2.68226 |
[BP] GO:0006811 |
None
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, FABP3, GRIA2, GRIA4, GRIK5, PPARA, SLC1A1 |
2.67838 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ALOX15, APP, EGFR, ERBB2, FLT3, GRM1, GRM5, HMGCR, KDR, MIF, MMP9, SRC, XDH |
2.66999 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, EGFR, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
2.65565 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, GRM5, IGF1R, PPARA, SRC |
2.65246 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APEX1, APP, CYP1A1, CYP1B1, EGFR, FLT3, PTAFR, SRC |
2.63707 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
2.63707 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ADRB1, APP, AXL, CBR1, CYP1A1, EGFR, ERBB2, FABP4, FLT3, FUT7, GLO1, HMGCR, KDR, MET, MIF, MMP2, MMP9, PTPRS, SRC, TERT, TOP2A |
2.60584 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, MIF, PIM1, PPARA, TYR |
2.60222 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.59865 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.59152 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ALOX15, APP, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MIF, MMP9, PPARA, SRC, XDH |
2.58253 |
[BP] GO:0051179 |
None
|
ABCB1, ACHE, ALOX15, ALOX5, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, EGFR, FABP3, GRIA2, GRIA4, GRIK5, MIF, MMP12, MMP9, PPARA, PTAFR, SLC1A1, SRC, TERT, TNKS, TNKS2, XDH |
2.58253 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, EGFR, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
2.58253 |
[BP] GO:0051338 |
regulation of transferase activity
|
APP, AURKB, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, MIF, SRC, TNKS |
2.57886 |
[BP] GO:0051234 |
None
|
ABCB1, ACHE, ALOX15, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, EGFR, FABP3, GRIA2, GRIA4, GRIK5, MIF, MMP12, MMP9, PPARA, PTAFR, SLC1A1, SRC, TERT, TNKS, XDH |
2.57397 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
ADRB1, MMP1, MMP12, MMP2, MMP9 |
2.53691 |
[BP] GO:1901654 |
None
|
AKR1B1, CA9, CSNK2A1, EGFR, PTAFR, SRC |
2.53234 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC, TNKS, TOP2A |
2.53088 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.52369 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.51824 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, SRC |
2.50847 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, APP, AURKB, CYP1A1, EGFR, MIF, SRC, TERT |
2.50245 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, EGFR, IGF1R, KDR, MET, MMP9, PTAFR, SRC, TERT |
2.48548 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.48034 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.48034 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ALOX15, APP, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MIF, MMP9, SRC, XDH |
2.45025 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, EGFR, MMP9, TERT |
2.44587 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ALOX15, APP, AURKB, CSNK2A1, EGFR, ERBB2, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.42181 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADRB1, APP, AURKB, EGFR, ERBB2, FLT3, GRM1, GRM5, MET, MIF, MMP9, PTAFR, SRC, TERT, TNKS, XDH |
2.4218 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, TERT, TNKS, TNKS2 |
2.36399 |
[BP] GO:1903959 |
None
|
ABCB1, GRM5, PTAFR |
2.36088 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.36088 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.34296 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.32818 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.32801 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.32801 |
[BP] GO:0042391 |
None
|
APP, CACNA1C, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
2.32094 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.31933 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
APP, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, MIF, SRC |
2.31531 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1A1, CYP1B1, HMGCR, KDR, SRC |
2.31131 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, EGFR, ERBB2, FABP3, FABP4, MET |
2.29987 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, MIF, PIM1, PPARA, TYR |
2.27418 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.27257 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADRB1, APP, AURKB, EGFR, ERBB2, FABP3, IGF1R, KDR, MET, MMP12, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, TOP2A |
2.26741 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.26605 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HMGCR, HSD17B1, HSD17B2 |
2.25976 |
[BP] GO:0050789 |
regulation of biological process
|
ABCB1, ACHE, ADORA3, ADRB1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, CA1, CA2, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPRS, SLC1A1, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.25826 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.25109 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA3, ADRB1, AKR1B1, ALOX15, APEX1, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, MIF, MMP2, MMP9, PPARA, PTAFR, SRC, TERT, TOP2A |
2.25109 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.25109 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.25109 |
[BP] GO:1901529 |
None
|
ABCB1, PTAFR |
2.25109 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.25109 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, APP, GRM5, IGF1R, SRC |
2.25109 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.24033 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, MIF, PIM1, PPARA, TYR |
2.22848 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.22693 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, SRC |
2.22693 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, MET, SRC, XDH |
2.22693 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
2.22412 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.2224 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, EGFR, IGF1R, SRC, TNKS, TNKS2 |
2.20933 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA3, ADRB1, ALOX15, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1A1, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.20348 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, CACNA1C, CYP19A1, EGFR, GRIK5, HMGCR, MIF, MMP12, PTAFR, SRC |
2.19452 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ALOX15, CYP19A1, EGFR, ERBB2, HMGCR, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTPRS, SRC, TERT, XDH |
2.17203 |
[BP] GO:1901992 |
positive regulation of mitotic cell cycle phase transition
|
APEX1, APP, CYP1A1, TERT |
2.16011 |
[BP] GO:1903524 |
None
|
ADRB1, EGFR, PTAFR, SLC1A1 |
2.16011 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.16011 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS |
2.14437 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.11654 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GRM5, IGF1R |
2.11654 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX15, ALOX5, CYP19A1, CYP1A1, HMGCR, MIF, PTAFR |
2.11302 |
[BP] GO:0043549 |
regulation of kinase activity
|
APP, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, MIF, SRC |
2.10295 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.10086 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA3, ADRB1, ALOX15, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.10077 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, EGFR, TNKS, TNKS2 |
2.09675 |
[BP] GO:0032845 |
None
|
HMGCR, MIF, SRC, TNKS, TNKS2 |
2.05242 |
[BP] GO:0050730 |
None
|
APP, EGFR, FLT3, GRM5, MIF, SRC |
2.05242 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, CYP1A1, HMGCR, MIF, TERT |
2.05242 |
[BP] GO:0007193 |
None
|
GRM1, GRM3, GRM5, GRM8 |
2.0466 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.0466 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA3, ADRB1, ALOX15, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.04193 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, EGFR, FUT7, KDR, MET, MIF, MMP1, MMP12, MMP9, PTAFR, SRC |
2.03719 |
[BP] GO:0042060 |
None
|
ALOX15, EGFR, ERBB2, PPARA |
2.03057 |
[BP] GO:0060078 |
None
|
GRIA2, GRIA4, GRIK5, GRM5 |
2.03057 |
[BP] GO:0032204 |
None
|
AURKB, SRC, TNKS, TNKS2 |
2.01028 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, HMGCR |
2.00917 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.00917 |
[BP] GO:1904645 |
response to amyloid-beta
|
APP, GRM5, IGF1R |
2.00917 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA3, ADRB1, ALOX15, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTAFR, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.00917 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ADORA3, ADRB1, ALOX15, APP, AXL, CA2, CA4, CA9, CACNA1C, EGFR, ERBB2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PTAFR, PTPRS, SLC1A1, SRC |
4.90611 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA3, ADRB1, ALOX15, APP, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, EGFR, ERBB2, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP2, PIM1, PTAFR, PTPRS, SLC1A1, SRC, TERT |
4.84507 |
[CC] GO:0098590 |
plasma membrane region
|
ABCB1, CA2, CA4, CA9, EGFR, ERBB2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, SLC1A1, SRC |
4.51149 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA3, ADRB1, ALOX15, ALOX5, APP, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD17B2, IGF1R, KDR, MET, MMP2, PIM1, PTAFR, PTPRS, SLC1A1, SRC, TERT, TNKS, TNKS2, TYR |
3.8909 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.45764 |
[CC] GO:0044456 |
None
|
ACHE, APP, CACNA1C, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, PTPRS, SRC |
3.34636 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA3, ADRB1, APP, AXL, CA4, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PTAFR, PTPRS, SLC1A1 |
3.22107 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA3, ADRB1, APP, AXL, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PTAFR, PTPRS, SLC1A1 |
2.86454 |
[CC] GO:0043235 |
receptor complex
|
APP, EGFR, ERBB2, GRIA2, GRIA4, GRIK5, GRM1, IGF1R |
2.84549 |
[CC] GO:0043226 |
organelle
|
ABCB1, ACHE, ADRB1, AKR1B1, AKR1B10, ALOX15, APEX1, APP, AURKB, AXL, CA1, CA2, CA4, CA9, CACNA1C, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, GLO1, GRIA4, GRIK5, GRM1, GRM3, GRM5, HMGCR, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PPARA, PTPRS, SLC1A1, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH |
2.4218 |
[CC] GO:0097060 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.35756 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, APEX1, APP, CA4, EGFR, ERBB2, SRC, TNKS2, TYR |
2.32818 |
[CC] GO:0014069 |
None
|
CACNA1C, GRIK5, GRM1, GRM3, GRM5, SRC |
2.32818 |
[CC] GO:0099572 |
None
|
CACNA1C, GRIK5, GRM1, GRM3, GRM5, SRC |
2.32818 |
[CC] GO:0043005 |
None
|
APP, CA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PTPRS, SRC, TUBB3 |
2.29987 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ACHE, ADORA3, ADRB1, ALOX15, APP, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD17B2, IGF1R, KDR, MET, PTAFR, PTPRS, SLC1A1, SRC, TYR |
2.28785 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADRB1, AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, APP, AURKB, CA1, CA2, CA4, CA7, CACNA1C, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, HMGCR, HSD17B1, HSD17B2, KDR, MIF, MMP2, MMP9, PIM1, PTAFR, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
2.18947 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCB1, ACHE, ADRB1, AKR1B1, AKR1B10, APEX1, APP, AURKB, AXL, CA1, CA2, CA4, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, GLO1, GRIA4, GRIK5, GRM1, GRM5, HMGCR, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PPARA, PTPRS, SLC1A1, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH |
2.00917 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.66878 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, TNKS, TYR, XDH |
8.92049 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, GLO1, HMGCR, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, PTPRS, SLC1A1, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH |
8.92049 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH |
8.81578 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.14444 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.82396 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.23612 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.90281 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.30616 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
5.2727 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, HSD17B2, TYR, XDH |
5.20006 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.33611 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA3, ADRB1, AXL, EGFR, ERBB2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PPARA, PTAFR |
4.06774 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, CBR1, HMGCR, HSD17B1, HSD17B2, XDH |
4.05115 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA3, ADRB1, AXL, EGFR, ERBB2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PTAFR |
3.95014 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA3, ADRB1, AXL, EGFR, ERBB2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PTAFR |
3.95014 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SLC1A1, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
3.7463 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.68098 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.67072 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.5241 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SLC1A1, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
3.5241 |
[MF] GO:0004872 |
receptor activity
|
ADORA3, ADRB1, AXL, EGFR, ERBB2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PPARA, PTAFR |
3.46454 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SRC, TOP2A |
3.45764 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, GLO1, MMP1, MMP12, MMP2, MMP9, PPARA, TNKS |
3.42113 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HMGCR, HSD17B1, HSD17B2 |
3.33143 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA3, ADRB1, AXL, EGFR, ERBB2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PPARA, PTAFR |
3.31712 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, ERBB2, KDR |
3.31712 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ALOX15, APP, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FABP3, FABP4, FLT3, HMGCR, HSD17B1, IGF1R, KDR, MET, PIM1, PTAFR, PTPRS, SLC1A1, SRC, TOP2A, TUBB3, XDH |
3.31712 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA3, ADRB1, AXL, EGFR, ERBB2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PPARA, PTAFR |
2.98904 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.90597 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.73147 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, CSNK2A1, EGFR, ERBB2, FLT3, GRIK5, HMGCR, IGF1R, KDR, MET, MIF, MMP9, TERT, TOP2A, TYR, XDH |
2.72167 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.71451 |
[MF] GO:0030594 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
2.4934 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.48034 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.48034 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.48034 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.32818 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.25109 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.2448 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FABP3, FABP4, FLT3, HMGCR, HSD17B1, IGF1R, KDR, MET, PIM1, SLC1A1, SRC, TOP2A, TUBB3, XDH |
2.20926 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, APEX1, CSNK2A1, EGFR, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, SRC |
2.16011 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.12153 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC, TERT |
2.07717 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.07477 |